News

News

Immune cells may be the key to tackling high blood pressure

Scientists have discovered new links between white blood cells and blood pressure, offering hope to those suffering from hypertension.

The study, led by a team at the BHF University of Edinburgh Centre for Cardiovascular Science (CVS), also revealed that current treatments could increase risk of the disorder.

Hypertension, or high blood pressure, affects more than 12 million people in the UK and is the leading cause of life-threatening conditions like heart attack, kidney disease, and stroke.

CTA scans reduce heart attack rates

A CVS study led by Professor David Newby indicates that a non-invasive diagnostic scan could cut heart attack rates and reduce risk of death from heart disease.

First randomised trial tests criteria used to diagnose heart attack

Results presented today at the 2018 European Society of Cardiology Congress call into question the current diagnostic definition of heart attack used by medical professionals.

Recent legislation linked to decreased numbers of drug-related hospital admissions

A CVS study suggests that temporary legislation put in place in 2015—combined with trading standards restrictions—decreased drug-related hospital admission rates in Edinburgh by 80%.

The Increasing Global Burden of HIV-Associated Heart Disease

HIV CV Disease

A CVS study reviewing data from 153 countries has revealed that HIV infection doubles the risk of heart disease. Additionally, the study showed that the global burden of HIV-associated cardiovascular disease has tripled in the past 20 years, and most greatly affects those in sub-Saharan Africa and Asia-Pacific regions. This study has important implications when planning cardiovascular preventative policies in low resource countries where the burden of HIV remains high and that of cardiovascular disease is growing.

Novel approach to studying calorie-burning fat tissue could help counteract obesity

Fluorodeoxyglucose PET image from one of the research subjects

Research, published in Cell Metabolism and carried out at CVS, has revealed a new way to study brown fat stores in the body. This novel approach could give us a better understanding of calorie-burning tissues and contribute to efforts to prevent weight gain and obesity.

CVS Staff and Students Demonstrating at Edinburgh International Science Festival

Staff and students from the Centre for Cardiovascular Science will present ‘Heart Factory’ at the Edinburgh International Science Festival on 5th and 6th April.

This project aims to explain, in a very interactive and simple way, the process of atherosclerotic plaque formation

BHF funding will help CVS researchers spot signs of inflammation that can lead to disease

original PET images from 18F-LW223, the new radiotracer, in rats.

CVS researchers, led by Dr Adriana Tavares, have been working on a new scanning tool based on positron emission tomography (PET) to target areas of inflammation in the body to help to better understand the role it plays in heart disease.

Blood test spots overdose patients at risk of liver damage

People who overdose on paracetamol could be helped by a blood test that shows immediately if they are going to suffer liver damage. Researchers at the Centre for Cardiovascular Science and the University of Liverpool say the test – which detects levels of specific molecules in blood – will help doctors identify which patients arriving in hospital need more intense treatment. It will also help speed the development of new therapies for liver damage by targeting patients most likely to benefit. The test detects three different molecules in the blood that are associated with liver damage – called miR-122, HMGB1 and FL-K18.

Low-cost Heart attack test could help patients across the globe

A low-cost, rapid blood test that spots whether people are at risk of a heart attack could improve the treatment of people with chest pain at emergency departments around the world, suggest CVS research findings published in the Journal of the American Medical Association on 11th November.